Amino Acid, Peptide, or Protein – Page 4 – Talk Bio

Actionable Insights Powered by AI

MoonLake revives FDA push; biotech trio to debut in Hong Kong

3 weeks ago talkbio0Tagged * * Investor Day, Asia, Biological Factors, Blackfoot language, Capital, Hidradenitis Suppurativa, Hong Kong, HS drug approval pathway, immunotherapeutics, License Application, Market, MIRA trial, MoonLake, sonelokimab, Type B meeting, United States Food and Drug Administration, VELA-1 trial, VELA-2 trial

MoonLake Immunotherapeutics; Sonelokimab; Hidradenitis Suppurativa; FDA Type B meeting; Biologics License Application; BLA H2 2026; VELA-1 trial; VELA-2 trial; MIRA trial; HS drug approval pathway; investor day February 23 2026; Hong Kong biotech IPOs; Hong Kong listing; Asia biotech capital markets

Just – Evotec Biologics Receives Gates Foundation Grant for AI-Driven Optimization of Monoclonal Antibody Developability

3 weeks ago talkbio0Tagged AI-driven, biotherapeutics, Country, developability, Drug Kinetics, Evotec SE, Financial cost, funding grant, Gates Foundation * *, Global Health, HIV, Immunogenicity (package insert), J.MD, low, Malaria, manufacturability, Manufactured Supplies, middle-income, Monoclonal Antibodies, Optimization, Platform, Respiratory syncytial virus, Stable status, Titer

Evotec SE; Gates Foundation; grant; J.MD; J.DESIGN platform; AI-driven optimization; monoclonal antibodies; biotherapeutics; developability; manufacturability; stability; immunogenicity; pharmacokinetics; titer; cost of goods; global health; affordable access; low- and middle-income countries; RSV; malaria; HIV

Trump Administration Overhauls Childhood Vaccine Schedule, Reducing Recommendations and Sparking Industry Backlash

3 weeks ago talkbio0Tagged Childhood Vaccines, Gardasil, human papillomavirus, public health debate, RFK Kennedy, Trump administration, vaccine schedule

vaccine schedule; childhood vaccines; Trump administration; RFK Kennedy; Gardasil HPV; public health debate

Rakuten Medical Raises $100 Million in Oversubscribed Series F for Photoimmunotherapy Platform

3 weeks ago talkbio0Tagged Alluminox, Cancer Therapeutic Procedure, methionine, Photoimmunotherapy, Rakuten Medical, regulatory approval, Series F

Rakuten Medical; Series F; $100M; photoimmunotherapy; cancer therapy; Alluminox; regulatory approval

Jazz and Zymeworks’ Ziihera Achieves Practice-Changing Results in Phase 3 Trial for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

3 weeks ago talkbio0Tagged erbB-2 Receptor, gastroesophageal adenocarcinoma, Jazz, Malignant neoplasm of stomach, Zanidatamab, Ziihera, Zymeworks

Ziihera; zanidatamab; Jazz Pharmaceuticals; Zymeworks; HER2; gastroesophageal adenocarcinoma; HERIZON-GEA-01; stomach cancer

FDA Memo Claims COVID Vaccine Linked to 10 Child Deaths, Faces Expert Skepticism and Criticism

3 weeks ago talkbio0Tagged COVID, Death of child, MEMO1 gene, United States Food and Drug Administration, Vaccine Safety, Vaccines, VAERS, Vinay Prasad

FDA memo; COVID vaccine; child deaths; Vinay Prasad; VAERS; vaccine safety

Roche’s Patent License Deal with Structure Therapeutics for CT-996 Obesity Drug

3 weeks ago talkbio0Tagged CT-996, genentech, Glucagon-Like Peptide 1, Obesity Drug, patent license, Roche (company), Structure Therapeutics

Roche; Structure Therapeutics; patent license; CT-996; obesity drug; Genentech; GLP-1

Vaccine Investors Stay Silent Amid Trump Administration’s Childhood Vaccine Schedule Cuts

4 weeks ago talkbio0Tagged Centers for Disease Control and Prevention (U.S.), Childhood Vaccines, Recommendation, RFK gene, Trump vaccine schedule, vaccine overhaul

Trump vaccine schedule; RFK Jr.; CDC recommendations; childhood vaccines; vaccine overhaul

Crinetics Reports Over $5M in Q4 2025 PALSONIFY Revenue with Strong Launch Metrics

4 weeks ago talkbio0Tagged Acromegaly, Crinetics, enrollment forms, methionine, PALSONIFY, prescribers, Q4 2025, Revenue

Crinetics; PALSONIFY; Palsonify; Q4 2025; revenue; $5M; acromegaly; enrollment forms; prescribers

Novo Nordisk Launches Wegovy Pill in the US with Broad Availability

4 weeks ago talkbio0Tagged Glucagon-Like Peptide 1, January 2026, Novo Nordisk, Oral cavity, U.S., Wegovy pill, Weight Loss

Novo Nordisk; Wegovy pill; US launch; January 2026; oral GLP-1; weight loss